Rare Diseases Orphan Product Development Act of 2002
United States Congress · 2002
Read Rare Diseases Orphan Product Development Act of 2002 by United States Congress (2002) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plaw-107-281-2002.txt.
Description
Public Law 107-281, the Rare Diseases Orphan Product Development Act of 2002, is the companion to the Rare Diseases Act passed the same day. It amends the Federal Food, Drug, and Cosmetic Act to push development of products for rare diseases.
Its findings repeat the problem. More than six thousand rare diseases affect about twenty-five million Americans. Yet drug makers rarely profit from medicines for such small groups. So treatments stayed unmade, and they earned the name orphan drugs. Where its sister act built a research office, this one works through the food and drug law to spur companies to develop treatments.
Catalog record
| CREATOR | United States Congress |
|---|---|
| YEAR | 2002 |
| COLLECTION | DECLASSIFIED |
| FORMAT | TXT |
| FILE SIZE | 4334 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Government Publishing Office (govinfo.gov) |